JPS6251010U - - Google Patents
Info
- Publication number
- JPS6251010U JPS6251010U JP14295385U JP14295385U JPS6251010U JP S6251010 U JPS6251010 U JP S6251010U JP 14295385 U JP14295385 U JP 14295385U JP 14295385 U JP14295385 U JP 14295385U JP S6251010 U JPS6251010 U JP S6251010U
- Authority
- JP
- Japan
- Prior art keywords
- shock absorber
- main shaft
- discharge port
- outer shell
- compressed gas
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Fluid-Damping Devices (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14295385U JPS6251010U (en:Method) | 1985-09-19 | 1985-09-19 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14295385U JPS6251010U (en:Method) | 1985-09-19 | 1985-09-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS6251010U true JPS6251010U (en:Method) | 1987-03-30 |
Family
ID=31052178
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP14295385U Pending JPS6251010U (en:Method) | 1985-09-19 | 1985-09-19 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6251010U (en:Method) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6456699A (en) * | 1987-02-05 | 1989-03-03 | Rejiyonaru De Toransufuyujion | Method for obtaining alpha 1-antitrypsin concentrate from human plasma and its utilization as drug |
-
1985
- 1985-09-19 JP JP14295385U patent/JPS6251010U/ja active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6456699A (en) * | 1987-02-05 | 1989-03-03 | Rejiyonaru De Toransufuyujion | Method for obtaining alpha 1-antitrypsin concentrate from human plasma and its utilization as drug |